Mitchell Kapoor Analyst PerformanceAnalyst at HC WainwrightMitchell Kapoor is a stock analyst at HC Wainwright in the healthcare sector, covering 33 publicly traded companies. Over the past year, Mitchell Kapoor has issued 10 stock ratings, including buy and hold recommendations. While full access to Mitchell Kapoor's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mitchell Kapoor's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings73 Last 1 YearsBuy Recommendations86.11% 62 Buy RatingsCompanies Covered33 Unique Companies Ratings Distribution72RatingsDistribution of strong buy, buy, hold, and sell ratings by Mitchell Kapoor.RatingPercentageCount Strong Buy0.0%0 ratings Buy86.1%62 ratings Hold13.9%10 ratings Sell0.0%0 ratingsOut of 72 total stock ratings issued by Mitchell Kapoor at HC Wainwright, the majority (86.1%) have been Buy recommendations, followed by 13.9% Hold.Best & Worst CallsBest Call0000.0%ALMSJul 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%TILJun 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ97.0% of companies on NASDAQ32 companiesNYSE3.0% of companies on NYSE1 companyMitchell Kapoor, an analyst at HC Wainwright, currently covers 33 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare33 companies100.0%Mitchell Kapoor of HC Wainwright specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY33 companies100.0% Mitchell Kapoor's Ratings History at HC Wainwright Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsGENBGenerate Biomedicines8/28/2026Boost Price Target$15.77$30.00Buy$0.0000.00% ROISRPTSarepta Therapeutics7/28/2026Reiterated Rating$15.89Buy$0.0000.00% ROICBIOCrescent Biopharma7/16/2026Reiterated Rating$15.67Neutral$0.0000.00% ROILEGNLegend Biotech7/16/2026Reiterated Rating$23.04Buy$0.0000.00% ROISMMTSummit Therapeutics7/15/2026Reiterated Rating$15.47Neutral$0.0000.00% ROIBMRNBioMarin Pharmaceutical7/14/2026Reiterated Rating$59.20Neutral$0.0000.00% ROIINCYIncyte7/14/2026Reiterated Rating$114.23Buy$0.0000.00% ROIEVMNEvommune1/6/2026Initiated Coverage$16.07$35.00Buy$0.0000.00% ROIMGTXMeiraGTx11/24/2025Initiated Coverage$7.46$20.00Buy$0.0000.00% ROIMGTXMeiraGTx11/24/2025Initiated Coverage$7.57$20.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. NTLAIntellia Therapeutics10/30/2025Set Price Target$12.52$18.00$00.0000.00% ROICRSPCRISPR Therapeutics8/7/2025Boost Price Target$56.34$80.00Buy$00.0000.00% ROIHALOHalozyme Therapeutics8/6/2025Boost Price Target$60.81$75.00Buy$00.0000.00% ROIIONSIonis Pharmaceuticals7/31/2025Reiterated Rating$43.37$65.00Buy$00.0000.00% ROIALMSAlumis7/25/2025Reiterated Rating$3.86$14.00Buy$00.0000.00% ROIKRROKorro Bio7/24/2025Reiterated Rating$16.85$100.00Buy$00.0000.00% ROIORKAOruka Therapeutics7/23/2025Reiterated Rating$14.06$45.00Buy$00.0000.00% ROILEGNLegend Biotech7/17/2025Reiterated Rating$39.75$75.00Buy$00.0000.00% ROILEGNLegend Biotech7/8/2025Reiterated Rating$35.87$75.00Buy$00.0000.00% ROITYRATyra Biosciences7/1/2025Reiterated Rating$9.57$30.00Buy$00.0000.00% ROISMMTSummit Therapeutics7/1/2025Reiterated Rating$21.28$44.00Buy$00.0000.00% ROILYELLyell Immunopharma6/24/2025Reiterated Rating$8.99$10.00Neutral$00.0000.00% ROITILInstil Bio6/5/2025Reiterated Rating$34.40$125.00Buy$0.0000.00% ROIBOLDBoundless Bio6/2/2025Initiated Coverage$1.10$5.00Buy$0.0000.00% ROIAVTXAvalo Therapeutics6/2/2025Upgrade$3.95$15.00Buy$00.0000.00% ROIHALOHalozyme Therapeutics5/29/2025Reiterated Rating$54.43$72.00Buy$00.0000.00% ROIKYTXKyverna Therapeutics5/27/2025Upgrade$2.27$5.00Buy$0.0000.00% ROITILInstil Bio5/22/2025Lower Price Target$16.22$105.00Buy$0.0000.00% ROILXEOLexeo Therapeutics5/16/2025Lower Price Target$2.70$15.00Buy$0.0000.00% ROICTMXCytomX Therapeutics5/15/2025Upgrade$2.38$5.00Buy$0.0000.00% ROINGNENeurogene5/13/2025Lower Price Target$17.70$45.00Buy$00.0000.00% ROIKRROKorro Bio5/8/2025Lower Price Target$13.84$100.00Buy$00.0000.00% ROIALMSAlumis4/30/2025Reiterated Rating$4.33$14.00Buy$00.0000.00% ROIEDITEditas Medicine4/28/2025Initiated Coverage$1.54$3.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics4/25/2025Reiterated Rating$59.25$72.00Buy$00.0000.00% ROILEGNLegend Biotech4/16/2025Reiterated Rating$33.74$75.00Buy$00.0000.00% ROILYELLyell Immunopharma4/16/2025Reiterated Rating$9.18$20.00Neutral$00.0000.00% ROIRNACCartesian Therapeutics4/9/2025Reiterated Rating$9.52$40.00Buy$0.0000.00% ROIRLYBRallybio4/9/2025Reiterated Rating$0.25Neutral$0.0000.00% ROILXEOLexeo Therapeutics4/8/2025Reiterated Rating$1.79$23.00Buy$0.0000.00% ROIMy prediction for December 8th (Ad)Elon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout.Download this free stock pick before December 8th arrivesLEGNLegend Biotech4/8/2025Reiterated Rating$30.25$75.00Buy$00.0000.00% ROIIONSIonis Pharmaceuticals4/7/2025Initiated Coverage$27.09$45.00Buy$00.0000.00% ROIKYTXKyverna Therapeutics4/3/2025Lower Price Target$2.15$4.00Neutral$0.0000.00% ROIMGXMetagenomi4/3/2025Lower Price Target$1.33$7.00Buy$0.0000.00% ROIZURAZura Bio4/3/2025Lower Price Target$1.17$3.00Neutral$0.0000.00% ROIIPSCCentury Therapeutics4/3/2025Lower Price Target$0.47$2.00Buy$0.0000.00% ROIRANIRani Therapeutics4/3/2025Reiterated Rating$1.39$9.00Buy$0.0000.00% ROITYRATyra Biosciences3/31/2025Reiterated Rating$9.77$30.00Buy$00.0000.00% ROILXEOLexeo Therapeutics3/26/2025Reiterated Rating$4.44$23.00Buy$0.0000.00% ROINGNENeurogene3/25/2025Lower Price Target$13.96$50.00Buy$00.0000.00% ROIABEOAbeona Therapeutics3/24/2025Reiterated Rating$5.15$15.00Buy$0.0000.00% ROIKRROKorro Bio3/20/2025Reiterated Rating$23.72$115.00Buy$00.0000.00% ROIRLYBRallybio3/17/2025Reiterated Rating$5.06$40.00Buy$0.0000.00% ROIRNACCartesian Therapeutics3/14/2025Lower Price Target$16.61$40.00Buy$0.0000.00% ROILYELLyell Immunopharma3/13/2025Reiterated Rating$13.43$20.00Neutral$00.0000.00% ROILEGNLegend Biotech3/12/2025Boost Price Target$37.19$75.00Buy$00.0000.00% ROICTMXCytomX Therapeutics3/7/2025Reiterated Rating$0.62Neutral$0.0000.00% ROIHALOHalozyme Therapeutics3/6/2025Reiterated Rating$59.53Buy$00.0000.00% ROINTLAIntellia Therapeutics3/5/2025Initiated Coverage$9.10$30.00Buy$00.0000.00% ROITILInstil Bio3/5/2025Reiterated Rating$17.50$110.00Buy$0.0000.00% ROISMMTSummit Therapeutics2/25/2025Reiterated Rating$18.84$44.00Buy$00.0000.00% ROIABEOAbeona Therapeutics2/19/2025Reiterated Rating$5.85$15.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics2/19/2025Boost Price Target$57.90$72.00Buy$00.0000.00% ROITYRATyra Biosciences2/18/2025Reiterated Rating$13.19$30.00Buy$00.0000.00% ROIRLYBRallybio2/12/2025Reiterated Rating$5.97$40.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics2/4/2025Reiterated Rating$56.28$70.00Buy$00.0000.00% ROICRSPCRISPR Therapeutics2/3/2025Initiated Coverage$41.59$65.00Buy$00.0000.00% ROIRNACCartesian Therapeutics1/28/2025Reiterated Rating$19.42$45.00Buy$0.0000.00% ROIIPSCCentury Therapeutics1/22/2025Reiterated Rating$0.90$5.00Buy$0.0000.00% ROILEGNLegend Biotech1/21/2025Reiterated Rating$32.66$73.00Buy$00.0000.00% ROIRLYBRallybio1/13/2025Reiterated Rating$7.52$40.00Buy$0.0000.00% ROITYRATyra Biosciences1/13/2025Reiterated Rating$15.20$30.00Buy$00.0000.00% ROIHALOHalozyme Therapeutics1/10/2025Boost Price Target$53.76$70.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital MarketsRaymond James Financial Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
